International Stem Cell Corp. (ISCO.OB) Announces Launch Plans for New Skin Care Products
International Stem Cell Corp. is a biotechnology company focused on creating therapeutic products using its proprietary parthenogenesis technology. This technology avoids ethical issues associated with using cells from human embryos. The company today announced the formation of a new joint marketing venture between it and a new firm to be formed by John Maudlin. Mr. Maudlin is a significant marketing talent, president of Millennium Wave Investments and author of an economic newsletter that goes to over 1.5 million readers. The joint venture is being set up to launch a line of skin care products developed by the company's wholly-owned subsidiary,…